$TAN Recent News Solar and the yen: Two ways to play an

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$TAN Recent News

Solar and the yen: Two ways to play an 'Apocalypse Later' market 6:30 a.m. June 17, 2014 - Shawn Langlois
Stock bulls go with the Fed’s easy flow 7:01 a.m. June 7, 2014 - Dave Fry
Bulls cherry pick data 10:02 p.m. May 22, 2014 - Dave Fry
Markets await big data day 5:01 a.m. May 15, 2014 - Dave Fry
Small-caps’ slide reflects a market in trouble 5:01 a.m. May 9, 2014 - Dave Fry
Nasdaq extends slide on tech slump; DJIA, S&P gain ground: Stock market live blog recap 4:22 p.m. May 7, 2014 - blogs.marketwatch.com
Stocks are moving on share buybacks, splits 6:02 a.m. April 25, 2014 - Dave Fry
Wash, rinse and repeat the Wall Street spin cycle 5:03 p.m. April 14, 2014 - Dave Fry
That screeching sound is the market losing momentum 8:59 p.m. April 6, 2014 - Dave Fry
Bulls see doves in Yellen’s comments 8:10 p.m. March 20, 2014 - Dave Fry
Investors jump back into solar stocks: Will they get burned again? 2:51 p.m. Feb. 27, 2014 - Claudia Assis
The stupidest investment ideas of 2013 7:00 a.m. Dec. 26, 2013 - Jeff Reeves
Six stocks to watch 4:39 p.m. Dec. 12, 2013 - The Trading Deck
Energy stocks fall; Chevron biggest Dow decliner 5:04 p.m. Nov. 1, 2013 - Claudia Assis
China-inspired moves, First Solar flies higher: The next 24 hours in markets 6:21 p.m. Oct. 31, 2013 - blogs.marketwatch.com
The Next 24: Is AIG Slimming Down? 4:41 p.m. Oct. 31, 2013 - MarketWatch
Options Trader action items 2:28 p.m. Oct. 17, 2013 - Lawrence G. McMillan
In focus: Trying to see through the haze 7:35 p.m. Oct. 16, 2013 - Lawrence G. McMillan
Winning ETFs in Q3: Solar, social, China tech 12:47 p.m. Sept. 30, 2013 - blogs.marketwatch.com
Solar power to overtake wind for the first time 10:47 a.m. Sept. 26, 2013 - Claudia Assis


The Solar Industry: Reality Check 12:33 p.m. July 22, 2014 - Seeking Alpha
Chinese solar stocks, SolarCity higher following WTO ruling 1:38 p.m. July 14, 2014 - Seeking Alpha
Terra Power And NRG Yield: What Is The Value Of Energy When Everyone Can Produce It? 9:53 a.m. July 10, 2014 - Seeking Alpha
Solar stocks drop; China reportedly thinking of cutting targets 10:08 a.m. July 8, 2014 - Seeking Alpha
Securities lending boosts Guggenheim's solar ETF 11:31 a.m. July 7, 2014 - Seeking Alpha
An Index-Beating Index ETF 4:47 p.m. July 6, 2014 - The Wall Street Journal Interactive Edition
Here are the WORST Calls of 2014 4:19 a.m. July 3, 2014 - InvestorPlace.com
SCTY, SUNE, SPWR, CSIQ, RGSE, up on Canaccord launches 9:49 a.m. July 2, 2014 - Seeking Alpha
Chinese Solar Companies Seek Options As A Response To U.S. Tariffs 11:28 a.m. June 26, 2014 - Seeking Alpha
The Solar Market Evolution 5:12 p.m. June 24, 2014 - Seeking Alpha
SolarCity and Yingli Boost Case for Solar Stocks 1:00 a.m. June 18, 2014 - InvestorPlace.com
Solar stocks jump following SolarCity, Yingli news 12:55 p.m. June 17, 2014 - Seeking Alpha
A Perfect Storm Brings SunPower Above Long-Term Resistance 11:31 a.m. June 17, 2014 - Seeking Alpha
ETF Outlook For Tuesday, June 17, 2014 (ARGT, THD, XLE, TAN, SUNE, SPWR) 9:39 a.m. June 17, 2014 - benzinga.com
ETF Outlook For Tuesday, June 17, 2014 (ARGT, THD, XLE, TAN, SUNE, SPWR) 9:39 a.m. June 17, 2014 - Benzinga.com
Solar stocks rally; Deutsche upbeat on YieldCo potential 11:05 a.m. June 16, 2014 - Seeking Alpha
A Fresh Look At Solar City Valuation 7:16 a.m. June 13, 2014 - Seeking Alpha
The Most Ineffective Trade War You Should Know About 8:36 a.m. June 12, 2014 - Seeking Alpha
Solar Is Getting Its Time In The Sun 9:10 p.m. June 11, 2014 - Seeking Alpha
China Sunergy: Slow Bleed To Death? 1:35 p.m. June 6, 2014 - Seeking Alpha

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 2

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 1

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading
GreenCore AI Agents Shatter Monthly Record in Ops Surge

Updated Category News Views 2

Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 1

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Crossware Joins Ingram Micro Platform for Wider Reach

Updated Category News Views 4

Email Signature Game Changer Taps New Markets What goes around comes around, they say. Well, in the email signature business, it seems Crossware is putting that old adage to bed by building a highway straight through Ingram Micro's Xvantage platform. Yep, Crossware's shaking hands with Ingram to spread its email signature prowess to even more necks of the woods,...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 5

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Raises Price Target for Blackstone Amid Encouraging Outlook

Updated Category News Views 86

Citi's Updated Outlook on Blackstone Recently, Citi revisited its financial forecast for The Blackstone Group (NYSE: BX), adjusting the price target upward from $157.00 to $170.00 while maintaining a Neutral stance on the stock. This update follows the company's impressive third-quarter performance, which saw Blackstone's stock rise by 6.3% post-earnings announcement....

Continue Reading
Digital Creators Ignite Sales in Premium Video

Updated Category News Views 16

Video Platforms: A New Playground for Digital Creators Alright, folks, let's kick things off with the latest juice on how digital creators are shaking up advertising in the premium video space. We're diving into research cooked up by the Video Advertising Bureau (VAB), and guess what? These creators wield some serious influence. This is not your run-of-the-mill social...

Continue Reading
Top Dividend-Yielding Tech and Telecom Stocks to Watch

Updated Category News Views 209

Investing in High-Dividend Stocks: An Insight In today's fluctuating market, many investors seek stability through dividend-yielding stocks. These stocks typically come from companies with strong cash flows and share their profits with investors via dividends. This approach not only offers potential income but can also be a safeguard during turbulent times. Highlighting...

Continue Reading
PHX Minerals Set to Release Full-Year 2024 Financial Results

Updated Category News Views 171

PHX Minerals Reveals Upcoming Financial Results Announcement PHX MINERALS INC., commonly known as PHX, is preparing to share its financial results for the year that concluded on December 31, 2024. This announcement is eagerly awaited by investors and stakeholders, marking a significant moment in understanding the company’s financial health and future outlook. Details of...

Continue Reading
Exploring Recent Advancements in CARVYKTI and LUCAR-G39D Therapies

Updated Category News Views 333

Significant Clinical Advancements in CARVYKTI® Therapy Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the field of cell therapy, has recently shared exceptional long-term clinical outcomes for CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) based on the CARTITUDE-1 and CARTITUDE-4 studies. Notably, patients who were triple-class exposed and had...

Continue Reading